Ritlecitinib and brepocitinib phase 2a randomized trial results review for alopecia areata treatment
Journal of the European Academy of Dermatology and Venereology | Jan 28, 2022
Most read this week
Journal of the European Academy of Dermatology and Venereology | Jan 28, 2022